{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:24:13Z","timestamp":1793021053369,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["MH107369"],"award-info":[{"award-number":["MH107369"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["NS075449"],"award-info":[{"award-number":["NS075449"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","award":["RB3-05009"],"award-info":[{"award-number":["RB3-05009"]}],"id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007557","name":"California Institute of Regenerative Medicine","doi-asserted-by":"publisher","award":["RB4-06045"],"award-info":[{"award-number":["RB4-06045"]}],"id":[{"id":"10.13039\/100007557","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13073-016-0347-3","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T11:29:51Z","timestamp":1474457391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model"],"prefix":"10.1186","volume":"8","author":[{"given":"Nils","family":"Grabole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao David","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Aigner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Ruderisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix C.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Theron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Berntenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Spleiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene W.","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Jagasia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kiialainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,21]]},"reference":[{"key":"347_CR1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274\u201393.","journal-title":"Cell."},{"key":"347_CR2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP. The tuberous sclerosis complex. N Engl J Med. 2006;355:1345\u201356.","journal-title":"N Engl J Med."},{"key":"347_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(08)61279-9","volume":"372","author":"P Curatolo","year":"2008","unstructured":"Curatolo P, Bombardieri R, Jozwiak S. Tuberous sclerosis. Lancet. 2008;372:657\u201368.","journal-title":"Lancet."},{"key":"347_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.spen.2006.01.008","volume":"13","author":"T Rosser","year":"2006","unstructured":"Rosser T, Panigrahy A, McClintock W. The diverse clinical manifestations of tuberous sclerosis complex: a review. Semin Pediatr Neurol. 2006;13:27\u201336.","journal-title":"Semin Pediatr Neurol."},{"key":"347_CR5","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/jnen\/63.12.1236","volume":"63","author":"JA Chan","year":"2004","unstructured":"Chan JA, Zhang H, Roberts PS, Jozwiak S, Wieslawa G, Lewin-Kowalik J, et al. Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation. J Neuropathol Exp Neurol. 2004;63:1236\u201342.","journal-title":"J Neuropathol Exp Neurol."},{"key":"347_CR6","first-page":"1639","volume":"151","author":"EP Henske","year":"1997","unstructured":"Henske EP, Wessner LL, Golden J, Scheithauer BW, Vortmeyer AO, Zhuang Z, et al. Loss of tuberin in both subependymal giant cell astrocytomas and angiomyolipomas supports a two-hit model for the pathogenesis of tuberous sclerosis tumors. Am J Pathol. 1997;151:1639\u201347.","journal-title":"Am J Pathol."},{"key":"347_CR7","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/WNL.0b013e3181e04325","volume":"74","author":"PB Crino","year":"2010","unstructured":"Crino PB, Aronica E, Baltuch G, Nathanson KL. Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology. 2010;74:1716\u201323.","journal-title":"Neurology."},{"key":"347_CR8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1177\/08830738040190090401","volume":"19","author":"FJ DiMario","year":"2004","unstructured":"DiMario FJ. Brain abnormalities in tuberous sclerosis complex. J Child Neurol. 2004;19:650\u20137.","journal-title":"J Child Neurol."},{"key":"347_CR9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.20784","volume":"59","author":"DN Franz","year":"2006","unstructured":"Franz DN, Leonard J, Tudor C, Chuck G, Care M, Sethuraman G, et al. Rapamycin causes regression of astrocytomas in tuberous sclerosis complex. Ann Neurol. 2006;59:490\u20138.","journal-title":"Ann Neurol."},{"key":"347_CR10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz DN, Belousova E, Sparagana S, Bebin EM, Frost M, Kuperman R, et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet. 2013;381:125\u201332.","journal-title":"Lancet."},{"key":"347_CR11","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1101\/gad.16750211","volume":"25","author":"J Zhou","year":"2011","unstructured":"Zhou J, Shrikhande G, Xu J, McKay RM, Burns DK, Johnson JE, et al. Tsc1 mutant neural stem\/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev. 2011;25:1595\u2013600.","journal-title":"Genes Dev."},{"key":"347_CR12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.stem.2011.09.008","volume":"9","author":"L Magri","year":"2011","unstructured":"Magri L, Cambiaghi M, Cominelli M, Alfaro-Cervello C, Cursi M, Pala M, et al. Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell. 2011;9:447\u201362.","journal-title":"Cell Stem Cell."},{"key":"347_CR13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.nbd.2011.08.024","volume":"45","author":"RP Carson","year":"2012","unstructured":"Carson RP, Van Nielen DL, Winzenburger PA, Ess KC. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol Dis. 2012;45:369\u201380.","journal-title":"Neurobiol Dis."},{"key":"347_CR14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/glia.10324","volume":"46","author":"KC Ess","year":"2004","unstructured":"Ess KC, Uhlmann EJ, Li W, Li H, Declue JE, Crino PB, et al. Expression profiling in tuberous sclerosis complex (TSC) knockout mouse astrocytes to characterize human TSC brain pathology. Glia. 2004;46:28\u201340.","journal-title":"Glia."},{"key":"347_CR15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/mcne.2002.1184","volume":"21","author":"H Onda","year":"2002","unstructured":"Onda H. Tsc2 null murine neuroepithelial cells are a model for human tuber giant cells, and show activation of an mTOR pathway. Mol Cell Neurosci. 2002;21:561\u201374.","journal-title":"Mol Cell Neurosci."},{"key":"347_CR16","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cell.2015.02.045","volume":"161","author":"D-F Lee","year":"2015","unstructured":"Lee D-F, Su J, Kim HS, Chang B, Papatsenko D, Zhao R, et al. Modeling familial cancer with induced pluripotent stem cells. Cell. 2015;161:240\u201354.","journal-title":"Cell."},{"issue":"Suppl 2","key":"347_CR17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2008.01493.x","volume":"49","author":"AA Sosunov","year":"2008","unstructured":"Sosunov AA, Wu X, Weiner HL, Mikell CB, Goodman RR, Crino PD, et al. Tuberous sclerosis: a primary pathology of astrocytes? Epilepsia. 2008;49 Suppl 2:53\u201362.","journal-title":"Epilepsia."},{"key":"347_CR18","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.celrep.2016.02.090","volume":"15","author":"V Costa","year":"2016","unstructured":"Costa V, Aigner S, Vukcevic M, Sauter E, Behr K, Ebeling M, et al. mTORC1 inhibition corrects neurodevelopmental and synaptic alterations in a human stem cell model of tuberous sclerosis. Cell Rep. 2016;15:86\u201395.","journal-title":"Cell Rep."},{"key":"347_CR19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/bioinformatics\/btp120","volume":"25","author":"C Trapnell","year":"2009","unstructured":"Trapnell C, Pachter L, Salzberg SL. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics. 2009;25:1105\u201311.","journal-title":"Bioinformatics."},{"key":"347_CR20","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25:2078\u20139.","journal-title":"Bioinformatics."},{"key":"347_CR21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"347_CR22","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1093\/nar\/gks461","volume":"40","author":"D Wu","year":"2012","unstructured":"Wu D, Smyth GK. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 2012;40:e133\u20133.","journal-title":"Nucleic Acids Res."},{"key":"347_CR23","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47\u20137.","journal-title":"Nucleic Acids Res"},{"key":"347_CR24","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/bioinformatics\/btt533","volume":"29","author":"AB Olshen","year":"2013","unstructured":"Olshen AB, Hsieh AC, Stumpf CR, Olshen RA, Ruggero D, Taylor BS. Assessing gene-level translational control from ribosome profiling. Bioinformatics. 2013;29:2995\u20133002.","journal-title":"Bioinformatics."},{"key":"347_CR25","doi-asserted-by":"crossref","first-page":"e17540","DOI":"10.1371\/journal.pone.0017540","volume":"6","author":"SH Yuan","year":"2011","unstructured":"Yuan SH, Martin J, Elia J, Flippin J, Paramban RI, Hefferan MP, et al. Cell-surface marker signatures for the isolation of neural stem cells, glia and neurons derived from human pluripotent stem cells. PLoS ONE. 2011;6:e17540\u201316.","journal-title":"PLoS ONE."},{"key":"347_CR26","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nbt.1562","volume":"27","author":"D Hockemeyer","year":"2009","unstructured":"Hockemeyer D, Soldner F, Beard C, Gao Q, Mitalipova M, DeKelver RC, et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases. Nat Biotechnol. 2009;27:851\u20137.","journal-title":"Nat Biotechnol."},{"key":"347_CR27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/prca.201400150","volume":"9","author":"T Dunkley","year":"2015","unstructured":"Dunkley T, Costa V, Friedlein A, Lugert S, Aigner S, Ebeling M, et al. Characterization of a human pluripotent stem cell-derived model of neuronal development using multiplexed targeted proteomics. Proteomics Clin Appl. 2015;9:684\u201394.","journal-title":"Proteomics Clin Appl."},{"key":"347_CR28","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1093\/hmg\/ddp025","volume":"18","author":"SW Way","year":"2009","unstructured":"Way SW, McKenna J, Mietzsch U, Reith RM, Wu HCJ, Gambello MJ. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet. 2009;18:1252\u201365.","journal-title":"Hum Mol Genet."},{"key":"347_CR29","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1002\/cne.23380","volume":"521","author":"U Mietzsch","year":"2013","unstructured":"Mietzsch U, McKenna III J, Reith RM, Way SW, Gambello MJ. Comparative analysis of Tsc1and Tsc2single and double radial glial cell mutants. J Comp Neurol. 2013;521:3817\u201331.","journal-title":"J Comp Neurol."},{"key":"347_CR30","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1523\/JNEUROSCI.5540-06.2007","volume":"27","author":"L Meikle","year":"2007","unstructured":"Meikle L, Talos DM, Onda H, Pollizzi K, Rotenberg A, Sahin M, et al. A mouse model of tuberous sclerosis: neuronal loss of TSC1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci. 2007;27:5546\u201358.","journal-title":"J Neurosci."},{"key":"347_CR31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1172\/JCI44909","volume":"121","author":"DM Feliciano","year":"2011","unstructured":"Feliciano DM, Su T, Lopez J, Platel J-C, Bordey A. Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J Clin Invest. 2011;121:1596\u2013607.","journal-title":"J Clin Invest."},{"key":"347_CR32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1440-1789.2008.00920.x","volume":"28","author":"K Boer","year":"2008","unstructured":"Boer K, Troost D, Jansen F, Nellist M, van den Ouweland AMW, Geurts JJG, et al. Clinicopathological and immunohistochemical findings in an autopsy case of tuberous sclerosis complex. Neuropathology. 2008;28:577\u201390.","journal-title":"Neuropathology."},{"key":"347_CR33","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nn1440","volume":"8","author":"F He","year":"2005","unstructured":"He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, Zhu W, et al. A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci. 2005;8:616\u201325.","journal-title":"Nat Neurosci."},{"key":"347_CR34","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1523\/JNEUROSCI.1709-08.2008","volume":"28","author":"JE Herrmann","year":"2008","unstructured":"Herrmann JE, Imura T, Song B, Qi J, Ao Y, Nguyen TK, et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci. 2008;28:7231\u201343.","journal-title":"J Neurosci."},{"key":"347_CR35","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2307\/2347127","volume":"23","author":"MO Hill","year":"1974","unstructured":"Hill MO. Correspondence analysis: a neglected multivariate method. Appl Stat. 1974;23:340\u201354.","journal-title":"Appl Stat."},{"key":"347_CR36","doi-asserted-by":"crossref","first-page":"6391","DOI":"10.1523\/JNEUROSCI.6221-11.2012","volume":"32","author":"JL Zamanian","year":"2012","unstructured":"Zamanian JL, Xu L, Foo LC, Nouri N, Zhou L, Giffard RG, et al. Genomic analysis of reactive astrogliosis. J Neurosci. 2012;32:6391\u2013410.","journal-title":"J Neurosci."},{"key":"347_CR37","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1750-3639.2009.00341.x","volume":"20","author":"K Boer","year":"2010","unstructured":"Boer K, Crino PB, Gorter JA, Nellist M, Jansen FE, Spliet WGM, et al. Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors. Brain Pathol. 2010;20:704\u201319.","journal-title":"Brain Pathol."},{"key":"347_CR38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.eplepsyres.2007.10.002","volume":"78","author":"K Boer","year":"2008","unstructured":"Boer K, Jansen F, Nellist M, Redeker S, van den Ouweland AMW, Spliet WGM, et al. Inflammatory processes in cortical tubers and subependymal giant cell tumors of tuberous sclerosis complex. Epilepsy Res. 2008;78:7\u201321.","journal-title":"Epilepsy Res."},{"key":"347_CR39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0969-9961(03)00127-X","volume":"14","author":"M Maldonado","year":"2003","unstructured":"Maldonado M, Baybis M, Newman D, Kolson DL, Chen W, McKhann II G, et al. Expression of ICAM-1, TNF-\u03b1, NFkB, and MAP kinase in tubers of the tuberous sclerosis complex. Neurobiol Dis. 2003;14:279\u201390.","journal-title":"Neurobiol Dis."},{"key":"347_CR40","first-page":"929","volume":"167","author":"AM Iyer","year":"2010","unstructured":"Iyer AM, Zurolo E, Boer K, Baayen JC, Giangaspero F, Arcella A, et al. Tissue plasminogen activator and urokinase plasminogen activator in human epileptogenic pathologies. NSC. 2010;167:929\u201345.","journal-title":"NSC."},{"key":"347_CR41","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/NEN.0b013e3181eaeae5","volume":"69","author":"H-F Shu","year":"2010","unstructured":"Shu H-F, Zhang C-Q, Yin Q, An N, Liu S-Y, Yang H. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. J Neuropathol Exp Neurol. 2010;69:838\u201349.","journal-title":"J Neuropathol Exp Neurol."},{"key":"347_CR42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/jcmm.12237","volume":"18","author":"E Lesma","year":"2014","unstructured":"Lesma E, Ancona S, Sirchia SM, Orpianesi E, Grande V, Colapietro P, et al. TSC2epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival. J Cell Mol Med. 2014;18:766\u201379.","journal-title":"J Cell Mol Med"},{"key":"347_CR43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nbd.2015.04.016","volume":"80","author":"B Zhang","year":"2015","unstructured":"Zhang B, Zou J, Rensing NR, Yang M, Wong M. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex. Neurobiol Dis. 2015;80:70\u20139.","journal-title":"Neurobiol Dis."},{"key":"347_CR44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1101\/gad.887201","volume":"15","author":"AC Gingras","year":"2001","unstructured":"Gingras AC, Raught B, Sonenberg N. Regulation of translation initiation by FRAP\/mTOR. Genes Dev. 2001;15:807\u201326.","journal-title":"Genes Dev."},{"key":"347_CR45","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2011.10.002","volume":"147","author":"NT Ingolia","year":"2011","unstructured":"Ingolia NT, Lareau LF, Weissman JS. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell. 2011;147:789\u2013802.","journal-title":"Cell."},{"key":"347_CR46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nature11083","volume":"486","author":"CC Thoreen","year":"2012","unstructured":"Thoreen CC, Chantranupong L, Keys HR, Wang T, Gray NS, Sabatini DM. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature. 2012;486:109\u201313.","journal-title":"Nature."},{"key":"347_CR47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature10912","volume":"485","author":"AC Hsieh","year":"2012","unstructured":"Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A, et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature. 2012;485:55\u201361.","journal-title":"Nature."},{"key":"347_CR48","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2015.05.049","volume":"162","author":"ML Truitt","year":"2015","unstructured":"Truitt ML, Conn CS, Shi Z, Pang X, Tokuyasu T, Coady AM, et al. Differential requirements for eIF4E dose in normal development and cancer. Cell. 2015;162:59\u201371.","journal-title":"Cell."},{"key":"347_CR49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nrc1015","volume":"3","author":"D Ruggero","year":"2003","unstructured":"Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer. 2003;3:179\u201392.","journal-title":"Nat Rev Cancer."},{"key":"347_CR50","doi-asserted-by":"crossref","first-page":"a012336","DOI":"10.1101\/cshperspect.a012336","volume":"5","author":"D Ruggero","year":"2013","unstructured":"Ruggero D. Translational control in cancer etiology. Cold Spring Harb Perspect Biol. 2013;5:a012336.","journal-title":"Cold Spring Harb Perspect Biol."},{"key":"347_CR51","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1067\/mjd.2002.120530","volume":"46","author":"JL Arbiser","year":"2002","unstructured":"Arbiser JL, Brat D, Hunter S, D\u2019Armiento J, Henske EP, Arbiser ZK, et al. Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. J Am Acad Dermatol. 2002;46:376\u201380.","journal-title":"J Am Acad Dermatol."},{"key":"347_CR52","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.ccell.2015.10.004","volume":"28","author":"S Sun","year":"2015","unstructured":"Sun S, Chen S, Liu F, Wu H, McHugh J, Bergin IL, et al. Constitutive activation of mTORC1 in endothelial cells leads to the development and progression of lymphangiosarcoma through VEGF autocrine signaling. Cancer Cell. 2015;28:758\u201372.","journal-title":"Cancer Cell."},{"key":"347_CR53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","volume":"74","author":"DA Krueger","year":"2013","unstructured":"Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, et al. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol. 2013;74:679\u201387.","journal-title":"Ann Neurol."},{"key":"347_CR54","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1158\/0008-5472.CAN-09-1751","volume":"70","author":"CM Chresta","year":"2010","unstructured":"Chresta CM, Davies BR, Hickson I, Harding T, Cosulich S, Critchlow SE, et al. AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity. Cancer Res. 2010;70:288\u201398.","journal-title":"Cancer Res."},{"key":"347_CR55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/glia.20207","volume":"50","author":"M Pekny","year":"2005","unstructured":"Pekny M, Nilsson M. Astrocyte activation and reactive gliosis. Glia. 2005;50:427\u201334.","journal-title":"Glia."},{"key":"347_CR56","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fncel.2013.00025","volume":"7","author":"R Krencik","year":"2013","unstructured":"Krencik R, Ullian EM. A cellular star atlas: using astrocytes from human pluripotent stem cells for disease studies. Front Cell Neurosci. 2013;7:25.","journal-title":"Front Cell Neurosci."},{"key":"347_CR57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.conb.2014.03.005","volume":"27","author":"SA Sloan","year":"2014","unstructured":"Sloan SA, Barres BA. Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders. Curr Opin Neurobiol. 2014;27:75\u201381.","journal-title":"Curr Opin Neurobiol."},{"key":"347_CR58","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.stem.2007.07.008","volume":"1","author":"B Hegedus","year":"2007","unstructured":"Hegedus B, Dasgupta B, Shin JE, Emnett RJ, Hart-Mahon EK, Elghazi L, et al. Neurofibromatosis-1 regulates neuronal and glial cell differentiation from neuroglial progenitors in vivo by both cAMP- and Ras-dependent mechanisms. Cell Stem Cell. 2007;1:443\u201357.","journal-title":"Cell Stem Cell."},{"key":"347_CR59","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ydbio.2009.04.010","volume":"330","author":"A Paquin","year":"2009","unstructured":"Paquin A, Hordo C, Kaplan DR, Miller FD. Costello syndrome H-Ras alleles regulate cortical development. Dev Biol. 2009;330:440\u201351.","journal-title":"Dev Biol."},{"key":"347_CR60","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neuron.2007.03.027","volume":"54","author":"AS Gauthier","year":"2007","unstructured":"Gauthier AS, Furstoss O, Araki T, Chan R, Neel BG, Kaplan DR, et al. Control of CNS cell-fate decisions by SHP-2 and its dysregulation in Noonan syndrome. Neuron. 2007;54:245\u201362.","journal-title":"Neuron."},{"key":"347_CR61","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1073\/pnas.1016933108","volume":"108","author":"J Urosevic","year":"2011","unstructured":"Urosevic J, Sauzeau V, Soto-Montenegro ML, Reig S, Desco M, Wright EMB, et al. Constitutive activation of B-Raf in the mouse germ line provides a model for human cardio-facio-cutaneous syndrome. Proc Natl Acad Sci U S A. 2011;108:5015\u201320.","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-016-0347-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T13:55:20Z","timestamp":1718805320000},"score":1,"resource":{"primary":{"URL":"http:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-016-0347-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,21]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["347"],"URL":"https:\/\/doi.org\/10.1186\/s13073-016-0347-3","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,21]]},"article-number":"94"}}